135 related articles for article (PubMed ID: 4075656)
1. Iodine-131 labeled anti-CEA antibodies uptake by Hürthle cell carcinoma.
Abdel-Nabi H; Hinkle GH; Falko JM; Kelly D; Olsen JO; Martin EW
Clin Nucl Med; 1985 Oct; 10(10):713-5. PubMed ID: 4075656
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunoscintigraphy using iodine-131-anti-CEA monoclonal antibodies and thallium-201 scintigraphy in medullary thyroid carcinoma: a case report.
Zanin DE; van Dongen A; Hoefnagel CA; Bruning PF
J Nucl Med; 1990 Nov; 31(11):1854-5. PubMed ID: 2231001
[TBL] [Abstract][Full Text] [Related]
3. Immunoscintigraphy in medullary thyroid cancer using an 123I- or 111In-labelled monoclonal anti-CEA antibody fragment.
Reiners C; Eilles C; Spiegel W; Becker W; Börner W
Nuklearmedizin; 1986 Dec; 25(6):227-31. PubMed ID: 3808964
[TBL] [Abstract][Full Text] [Related]
4. Thyroid cancer with a high 123I-NaI uptake in primary and metastatic foci with euthyroidism.
Nakayama C; Nakata H; Zeze F; Eto S; Ichiya Y
Eur J Nucl Med; 1987; 13(9):480-1. PubMed ID: 3440474
[TBL] [Abstract][Full Text] [Related]
5. Localization of I-131-labeled goat and primate anti-carcinoembryonic antigen(CEA) antibodies in patients with cancer.
Sullivan DC; Silva JS; Cox CE; Haagensen DE; Harris CC; Briner WH; Wells SA
Invest Radiol; 1982; 17(4):350-5. PubMed ID: 6752092
[TBL] [Abstract][Full Text] [Related]
6. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
Behr TM; Gratz S; Markus PM; Dunn RM; Hüfner M; Schauer A; Fischer M; Munz DL; Becker H; Becker W
Cancer; 1997 Dec; 80(12 Suppl):2436-57. PubMed ID: 9406695
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-anti-CEA radioimmunoscintigraphy of lung adenocarcinoma.
Leitha T; Walter R; Schlick W; Dudczak R
Chest; 1991 Jan; 99(1):14-9. PubMed ID: 1984945
[TBL] [Abstract][Full Text] [Related]
8. Aggressive poorly differentiated adenocarcinoma of the lung diagnosed 13 months after initial diagnosis of papillary thyroid carcinoma with "non-iodine concentrating" pulmonary metastasis.
Basu S; Rekhi B; Shamim SA; Jambhekar NA
Hell J Nucl Med; 2012; 15(3):252-3. PubMed ID: 23227462
[No Abstract] [Full Text] [Related]
9. Evaluation of primary lung cancer with indium 111 anti-carcinoembryonic antigen (type ZCE-025) monoclonal antibody scintigraphy.
Krishnamurthy S; Morris JF; Antonovic R; Ahmed A; Galey WT; Duncan C; Krishnamurthy GT
Cancer; 1990 Feb; 65(3):458-65. PubMed ID: 2297636
[TBL] [Abstract][Full Text] [Related]
10. Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen.
Juweid M; Sharkey RM; Behr T; Swayne LC; Rubin AD; Herskovic T; Hanley D; Markowitz A; Dunn R; Siegel J; Kamal T; Goldenberg DM
J Clin Oncol; 1996 Apr; 14(4):1209-17. PubMed ID: 8648376
[TBL] [Abstract][Full Text] [Related]
11. Imaging of pharyngeal and laryngeal carcinomas with indium-111-labeled monoclonal anti-CEA antibodies.
Kairemo KJ; Hopsu EV
Laryngoscope; 1990 Oct; 100(10 Pt 1):1077-82. PubMed ID: 2215039
[TBL] [Abstract][Full Text] [Related]
12. Immunoscintigraphy of adenocarcinomas by means of 111In-labelled F(ab')2 fragments of anti-CEA monoclonal antibody F023C5.
Riva P; Paganelli G; Callegaro L; Bartoli MG; Turci D; Benini S; Deleide G; Scassellati GA; Viale G; Siccardi AG
Nucl Med Commun; 1988 Aug; 9(8):577-89. PubMed ID: 3173916
[TBL] [Abstract][Full Text] [Related]
13. In-111 labeled monoclonal anti-carcinoembryonic antigen antibody (ZCE025) in the immunoscintigraphic imaging of metastatic antigen-producing adenocarcinomas.
Saleh MN; Wheeler RH; Lee JY; Khazaeli MB; Unger MW; Russell CH; LoBuglio AF
Clin Nucl Med; 1991 Feb; 16(2):110-6. PubMed ID: 2004491
[TBL] [Abstract][Full Text] [Related]
14. Radioiodine uptake by metastatic nonthyroidal adenocarcinoma of the lung in a patient with papillary thyroid carcinoma.
Sohn MH; Kim MW; Lim ST; Lee NR; Song EK; Yim CY
Clin Nucl Med; 2005 Apr; 30(4):269-70. PubMed ID: 15764888
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunoimaging of metastatic medullary carcinoma of the thyroid gland using an indium-111-labeled monoclonal antibody to CEA.
Edington HD; Watson CG; Levine G; Tauxe WN; Yousem SA; Unger M; Kowal CD
Surgery; 1988 Dec; 104(6):1004-10. PubMed ID: 3194829
[TBL] [Abstract][Full Text] [Related]
16. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
[TBL] [Abstract][Full Text] [Related]
17. Targeting and initial radioimmunotherapy of medullary thyroid carcinoma with 131I-labeled monoclonal antibodies to carcinoembryonic antigen.
Juweid M; Sharkey RM; Behr T; Swayne LC; Rubin AD; Hanley D; Herskovic T; Markowitz A; Siegel J; Goldenberg DM
Cancer Res; 1995 Dec; 55(23 Suppl):5946s-5951s. PubMed ID: 7493375
[TBL] [Abstract][Full Text] [Related]
18. Lymphoscintigraphy with radionuclide-labeled antibodies to carcinoembryonic antigen.
DeLand FH; Kim EE; Goldenberg DM
Cancer Res; 1980 Aug; 40(8 Pt 2):2997-3000. PubMed ID: 7397695
[TBL] [Abstract][Full Text] [Related]
19. [Successful immunoscintigraphic tumor detection with technetium 99m marked monoclonal anti-CEA antibodies].
Baum RP; Lorenz M; Hertel A; Baew-Christow T; Schwarz A; Hör G
Onkologie; 1989 Aug; 12 Suppl 1():26-9. PubMed ID: 2685692
[TBL] [Abstract][Full Text] [Related]
20. [Principles of radionuclide methods of diagnosing and treating primary thyroid cancer and its metastases].
Purizhanskiĭ II; Lushina LI; Lyzhina VD; Lisenkov PI
Med Radiol (Mosk); 1982 Oct; 27(10):61-6. PubMed ID: 7176859
[No Abstract] [Full Text] [Related]
[Next] [New Search]
